Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Hepion Pharmaceuticals stock (HEPA)

Buy Hepion Pharmaceuticals stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Hepion Pharmaceuticals is a biotechnology business based in the US. Hepion Pharmaceuticals shares (HEPA) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.18 – a decrease of 5.82% over the previous week. Hepion Pharmaceuticals employs 22 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Hepion Pharmaceuticals stock

Our pick for stock bonuses

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Get up to $1,000 in stock when you fund a new account within 30 days
  • Access to a financial planner
Probability of member receiving $1,000 is 0.028%

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

How to buy Hepion Pharmaceuticals stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – HEPA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Hepion Pharmaceuticals stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 6 of 6
Product USFST Finder Score Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
SoFi Wealth Management logo
Finder score
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
OPTO logo
Finder score
Stocks, ETFs
$0
$0
N/A
Earn up to $300
Tastytrade logo
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Robinhood logo
Finder score
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4%
Get a free stock
Public logo
Finder score
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.1%
Get up to $10,000 and transfer fees covered
JPMorgan logo
Finder score
Mutual funds, ETFs
$0
$25,000
N/A
N/A
loading

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Hepion Pharmaceuticals stock price (NASDAQ: HEPA)

Use our graph to track the performance of HEPA stocks over time.

Hepion Pharmaceuticals shares at a glance

Information last updated 2025-01-30.
Latest market close$0.18
52-week range$0.12 - $3.49
50-day moving average $0.53
200-day moving average $0.84
Wall St. target price$30.00
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-4.40

Is it a good time to buy Hepion Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Hepion Pharmaceuticals price performance over time

Historical closes compared with the close of $0.1795 from 2025-01-31

1 week (2025-01-27) 8.79%
1 month (2025-01-03) -71.82%
3 months (2024-11-01) -72.38%
6 months (2024-08-02) -75.44%
1 year (2024-02-02) -89.19%
2 years (2023-02-03) -98.88%
3 years (2022-02-03) 19.4
5 years (2020-02-03) 100.4

Hepion Pharmaceuticals financials

Gross profit TTM $0
Return on assets TTM -92.82%
Return on equity TTM -189.52%
Profit margin 0%
Book value $1.16
Market Capitalization $2 million

TTM: trailing 12 months

Hepion Pharmaceuticals share dividends

We're not expecting Hepion Pharmaceuticals to pay a dividend over the next 12 months.

Have Hepion Pharmaceuticals's shares ever split?

Hepion Pharmaceuticals's shares were split on a 1:20 basis on 10 May 2023 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Hepion Pharmaceuticals shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Hepion Pharmaceuticals shares which in turn could have impacted Hepion Pharmaceuticals's share price.

Hepion Pharmaceuticals share price volatility

Over the last 12 months, Hepion Pharmaceuticals's shares have ranged in value from as little as $0.121 up to $3.4899. A popular way to gauge a stock's volatility is its "beta".

HEPA.US volatility(beta: 1.81)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hepion Pharmaceuticals's is 1.813. This would suggest that Hepion Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Hepion Pharmaceuticals overview

Hepion Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the development of drug therapy treatment for chronic liver diseases in the United States. It develops Rencofilstat, a cyclophilin inhibitor is in Phase 2b clinical trial to target multiple pathologic pathways involved in the progression of liver disease and treat non-alcoholic steatohepatitis (NASH), as well as preclinical studies of Rencofilstat shows reduction in liver fibrosis, liver inflammation, liver tumor burden, and titers of HBV, HCV, HDV, and HIV-1, and has demonstrated antiviral activities for hepatitis B, C, and D viruses through several mechanisms. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc.

Frequently asked questions

null
What percentage of Hepion Pharmaceuticals is owned by insiders or institutions?
Currently 0.085% of Hepion Pharmaceuticals shares are held by insiders and 7.848% by institutions.
How many people work for Hepion Pharmaceuticals?
Latest data suggests 22 work at Hepion Pharmaceuticals.
When does the fiscal year end for Hepion Pharmaceuticals?
Hepion Pharmaceuticals's fiscal year ends in December.
Where is Hepion Pharmaceuticals based?
Hepion Pharmaceuticals's address is: 399 Thornall Street, Edison, NJ, United States, 08837
What is Hepion Pharmaceuticals's ISIN number?
Hepion Pharmaceuticals's international securities identification number is: US4268971045
What is Hepion Pharmaceuticals's CUSIP number?
Hepion Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 21234W400

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

More guides on Finder

Go to site